Hua Medicine
HKEX:2552
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hua Medicine
HKEX:2552
|
CN |
|
Al Baha Investment and Development Company SJSC
SAU:4130
|
SA |
|
Toyo Suisan Kaisha Ltd
TSE:2875
|
JP |
|
China XD Electric Co Ltd
SSE:601179
|
CN |
|
Golden Sky Minerals Corp
XTSX:AUEN
|
CA |
Cash Flow Statement
Cash Flow Statement
Hua Medicine
| Mar-2018 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
(449)
|
(1 559)
|
(3 604)
|
(2 333)
|
(425)
|
(363)
|
(393)
|
(385)
|
(326)
|
(265)
|
(204)
|
(189)
|
(211)
|
(263)
|
(250)
|
1 076
|
|
| Depreciation & Amortization |
1
|
1
|
2
|
5
|
10
|
19
|
18
|
22
|
32
|
32
|
32
|
34
|
36
|
36
|
35
|
34
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
74
|
105
|
59
|
48
|
33
|
30
|
21
|
16
|
24
|
20
|
12
|
9
|
|
| Other Non-Cash Items |
249
|
1 305
|
3 254
|
1 931
|
51
|
32
|
81
|
88
|
40
|
(0)
|
(31)
|
(22)
|
(67)
|
(103)
|
(94)
|
(1 292)
|
|
| Change in Working Capital |
(43)
|
(2)
|
79
|
50
|
22
|
1
|
272
|
258
|
(19)
|
8
|
(27)
|
323
|
1 131
|
734
|
(108)
|
(94)
|
|
| Cash from Operating Activities |
(242)
N/A
|
(255)
-5%
|
(269)
-6%
|
(347)
-29%
|
(342)
+1%
|
(311)
+9%
|
(21)
+93%
|
(18)
+15%
|
(273)
-1 434%
|
(225)
+17%
|
(230)
-2%
|
145
N/A
|
889
+512%
|
404
-55%
|
(418)
N/A
|
(276)
+34%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
(3)
|
(2)
|
(5)
|
(9)
|
(10)
|
(7)
|
(26)
|
(38)
|
(67)
|
(58)
|
(27)
|
(30)
|
(10)
|
(4)
|
(4)
|
(9)
|
|
| Other Items |
(13)
|
116
|
18
|
4
|
1
|
2
|
12
|
11
|
(1)
|
17
|
23
|
9
|
18
|
16
|
14
|
16
|
|
| Cash from Investing Activities |
(16)
N/A
|
114
N/A
|
12
-89%
|
(5)
N/A
|
(10)
-82%
|
(5)
+48%
|
(14)
-183%
|
(27)
-92%
|
(68)
-152%
|
(41)
+40%
|
(5)
+88%
|
(21)
-344%
|
8
N/A
|
12
+46%
|
10
-15%
|
7
-31%
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
777
|
739
|
1 516
|
779
|
7
|
6
|
8
|
8
|
10
|
10
|
11
|
18
|
10
|
2
|
2
|
5
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
(2)
|
(8)
|
(12)
|
(15)
|
(17)
|
(16)
|
(15)
|
11
|
133
|
64
|
50
|
89
|
(46)
|
|
| Other |
16
|
3
|
(51)
|
(34)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(2)
|
(5)
|
(6)
|
(7)
|
(7)
|
|
| Cash from Financing Activities |
793
N/A
|
741
-7%
|
1 465
+98%
|
743
-49%
|
(1)
N/A
|
(5)
-343%
|
(7)
-33%
|
(9)
-27%
|
(6)
+33%
|
(5)
+24%
|
21
N/A
|
149
+591%
|
69
-53%
|
45
-34%
|
84
+84%
|
(48)
N/A
|
|
| Change in Cash | |||||||||||||||||
| Effect of Foreign Exchange Rates |
(17)
|
25
|
63
|
36
|
15
|
25
|
(31)
|
(49)
|
(10)
|
10
|
29
|
22
|
4
|
(4)
|
3
|
1
|
|
| Net Change in Cash |
518
N/A
|
625
+21%
|
1 271
+103%
|
427
-66%
|
(338)
N/A
|
(297)
+12%
|
(74)
+75%
|
(103)
-40%
|
(357)
-248%
|
(261)
+27%
|
(185)
+29%
|
295
N/A
|
970
+229%
|
458
-53%
|
(321)
N/A
|
(316)
+2%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
(245)
N/A
|
(257)
-5%
|
(275)
-7%
|
(356)
-30%
|
(352)
+1%
|
(318)
+10%
|
(47)
+85%
|
(56)
-19%
|
(340)
-512%
|
(283)
+17%
|
(258)
+9%
|
115
N/A
|
880
+663%
|
400
-55%
|
(422)
N/A
|
(284)
+33%
|
|